Staphylococcal peptidoglycan (PGN)

Staphylococcal peptidoglycan is a critical structural polymer that forms the cell wall of Staphylococcus aureus and related species. It is composed of alternating N-acetylglucosamine and N-acetylmuramic acid residues cross-linked by peptide bridges, which in S. aureus include a unique pentaglycine interpeptide (Vollmer et al., 2008). This rigid structure is essential for maintaining bacterial cell shape and protecting against high internal osmotic pressure (Silhavy et al., 2010). As a therapeutic target, it is the primary binding site for glycopeptide antibiotics like vancomycin, which attach to the D-alanyl-D-alanine terminus of peptidoglycan precursors to block cell wall assembly (StatPearls, 2023). Beyond its structural role, peptidoglycan fragments are recognized by the host's innate immune system as pathogen-associated molecular patterns (PAMPs), primarily through the NOD2 receptor, leading to the production of pro-inflammatory cytokines (Nature, 2005). The clinical utility of targeting this molecule is challenged by the emergence of resistant strains, such as Vancomycin-Resistant S. aureus (VRSA), which modify the peptidoglycan precursor to evade drug binding (PubMed, 2014).

Other names

MureinBacterial cell wall peptidoglycanStaphylococcus aureus peptidoglycanPeptidoglycan layer

Inhibition of cell wall synthesis by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors, preventing transpeptidation and transglycosylation.